TITLE

Drug-Firm Group Prescribes Tauzin

AUTHOR(S)
Hearn, Ted
PUB. DATE
December 2004
SOURCE
Multichannel News;12/20/2004, Vol. 25 Issue 51, p44
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Reports on the appointment of former U.S. Representative Billy Tauzin (R-La.) as president and chief executive officer of the Pharmaceutical Research and Manufacturers of America. Major pharmaceutical companies represented by the lobbying group; Career of Tauzin as a legislator; Statement from Tauzin regarding his executive job.
ACCESSION #
15443290

 

Related Articles

  • What! No Pens?! Berliner, Neil // Pharmaceutical Representative;Sep2008, Vol. 38 Issue 9, p31 

    The author reflects on the PhRMA code in the pharmaceutical industry in the U.S. He states that PhRMA chief executive officer Billy Tauzin hopes that the code additions will create more credible standards for doctor-sales representative interactions. He comments on the statement from PhRMA that...

  • Billy Tauzin. Clinton, Patrick; Wechsler, Jill // Pharmaceutical Executive;Mar2005, Vol. 25 Issue 3, p54 

    Interviews Billy Tauzin, president and CEO of the Pharmaceutical Research and Manufacturers of America (PhRMA), regarding issues faced by pharmaceutical industries in the U.S. Missions as president and CEO; Suggestions on medicare; Views on the renewal of Prescription of Drug User Fee Act. ...

  • QUOTABLES.  // Pharmaceutical Executive;Jan2007, Vol. 27 Issue 1, p20 

    The article presents quotes from personalities in the pharmaceutical industry in the U.S. Billy Tauzin, president and CEO of PhRMA, stated that the worst thing that happened in the industry is that they got pushed into one political camp and have to support anyone that wants to help patients....

  • Capitol Hill Insider to Lead Industry. Weghsler, Jill // Pharmaceutical Executive;Jan2005, Vol. 25 Issue 1, p22 

    This article reports that the announcement last month that former Louisiana Republican Billy Tauzin would take over as president and CEO of PhRMA on January 3 ended months of speculation. Tauzin chaired the important House Energy & Commerce Committee until stepping down last Fehruary after...

  • Drug bill architect may be mulling PhRMA post. Fong, Tony // Modern Healthcare;2/2/2004, Vol. 34 Issue 5, p32 

    Presents information on the possible appointment of representative Billy Tauzin (R-La.) as chief executive officer of the Pharmaceutical Manufacturers of America. Views of the Common Cause, a non-partisan lobbyists, on the appointment of Tauzin; Role of Tauzin in the U.S. House-Senate...

  • The Rep -- and the Reputation. Clinton, Patrick // Pharmaceutical Executive;Mar2004, Vol. 24 Issue 3, p16 

    Focuses on the duties and responsibilities of Billy Tauzin, chairman of the Energy and Commerce Committee in helping the U.S. pharmaceutical industry. Inadequacy of the rules governing congressional behavior; Access of pharmaceutical industry to the lobbyists; Need for the industry to rebuild...

  • Duffy Moves Up at Maritz.  // Medical Meetings;Dec2004, Vol. 31 Issue 8, p76 

    Reports on the appointment of Christine Duffy as president and CEO of meetings, events, and incentive travel management company Maritz Travel. Information on the previous position held by Duffy; Amount saved by pharmaceutical companies from meetings with the use of Maritz McGettigan's meeting...

  • Tom McKillop. Guyon, Janet // Fortune International (Europe);7/26/2004, Vol. 150 Issue 2, Following pF42 

    Presents an interview with Tom McKillop, chief executive officer of AstraZeneca. Comments on industry consolidation; Merger of Astra and Zeneca; Cost of research and development; Symbiosis between the generics industry and the innovative industry; Analysis of the pharmaceutical industry and the...

  • Nazzari named president of Pharmitech 2004.  // Pharmaceutical Technology Europe;May2004, Vol. 16 Issue 5, p9 

    Pharmitech 2004, the inaugural event of the innovations exhibition for the pharmaceutical industry and related cosmetics and nutritional sectors to be held in Bologna, Italy, in June, has named Federico Nazzari as its president. Federico boasts 30 years' experience in the pharmaceutical arena,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics